Lead EvaluAtion for Defibrillation and Reliability (LEADR)

Recruiting
18 years - 99 years
All
500 participants needed
1 Location

Brief description of study

The research study is being conducted to assess the safety and efficacy of Medtronic’s Next Generation ICD lead. Duration 18 to 36 months.

Detailed description of study

The research study is being conducted to assess the safety and efficacy of Medtronic’s Next Generation ICD lead. Duration 18 to 36 months.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Heart, Cardiac, Defibrillation
  • Age: 18 years - 99 years
  • Gender: All

Adults diagnosed with heart disease whose doctor recommends implant of an ICD or CRT-D device.

Updated on 04 Aug 2024. Study ID: 850232

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center